Purchases and Sales Made in Q1 2024 in Janux Therapeutics, Inc. (JANX)
This table provides information about the institutional ownership of Janux Therapeutics, Inc. (JANX) during Q1 2024. The information is specifically focused on institutions that hold shares of Janux Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 14, 2024
Q1 2024
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-2.02K- 0.99% |
$16K - $100K
|
202K
$7.27M
|
|
|
May 13, 2024
Q1 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-2.95K- 3.62% |
$23.4K - $147K
|
78.6K
$2.83M
|
|
|
May 15, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-3.11K- 66.21% |
$24.7K - $155K
|
1.59K
$57.1K
|
|
|
May 15, 2024
Q1 2024
|
Alyeska Investment Group, L.P.
Chicago, IL |
SELL
|
- |
-4.44K- 2.25% |
$35.2K - $221K
|
193K
$6.95M
|
|
|
May 09, 2024
Q1 2024
|
Connor, Clark & Lunn Investment Management Ltd.
|
SELL
|
- |
-5.92K- 46.22% |
$47K - $295K
|
6.89K
$248K
|
|
|
Apr 15, 2024
Q1 2024
|
Exchange Traded Concepts, LLC
|
SELL
|
- |
-6.66K- 46.89% |
$52.8K - $331K
|
7.54K
$272K
|
|
|
May 15, 2024
Q1 2024
|
Zacks Investment Management
Chicago, IL |
SELL
|
- |
-17.9K- 30.41% |
$142K - $890K
|
40.9K
$1.47M
|
|
|
May 15, 2024
Q1 2024
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-18K- 29.45% |
$143K - $896K
|
43.2K
$1.55M
|
|
|
Apr 18, 2024
Q1 2024
|
Allspring Global Investments Holdings, LLC
|
SELL
|
- |
-19.9K- 75.83% |
$158K - $991K
|
6.35K
$229K
|
|
|
May 15, 2024
Q1 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-20.3K- 46.25% |
$161K - $1.01M
|
23.5K
$848K
|
|
|
Nov 05, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-22.9K- 93.53% |
$182K - $1.14M
|
1.59K
$57.1K
|
|
|
Feb 07, 2025
Q1 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-29.1K- 41.76% |
$231K - $1.45M
|
40.7K
$1.46M
|
|
|
Dec 06, 2024
Q1 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-29.1K- 41.76% |
$231K - $1.45M
|
40.7K
$1.46M
|
|
|
May 15, 2024
Q1 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-32.2K- 67.52% |
$256K - $1.6M
|
15.5K
$558K
|
|
|
May 14, 2024
Q1 2024
|
Cerity Partners LLC
New York, NY |
SELL
|
- |
-39.5K- 64.83% |
$313K - $1.97M
|
21.4K
$772K
|
|
|
May 15, 2024
Q1 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-66.1K- 91.95% |
$524K - $3.29M
|
5.78K
$208K
|
|
|
May 10, 2024
Q1 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-68.1K- 3.87% |
$540K - $3.39M
|
1.69M
$61M
|
|
|
Oct 07, 2024
Q1 2024
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-160K- 22.81% |
$1.27M - $7.97M
|
542K
$19.5M
|
|
|
May 15, 2024
Q1 2024
|
Samsara Bio Capital, LLC
Palo Alto, CA |
SELL
|
- |
-180K- 50.0% |
$1.43M - $8.97M
|
180K
$6.49M
|
|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-770K- 24.68% |
$6.11M - $38.3M
|
2.35M
$84.6M
|
|
|
May 15, 2024
Q1 2024
|
Bvf Inc
San Francisco, CA |
SELL
|
- |
-1.66M- 36.25% |
$13.2M - $82.6M
|
2.92M
$105M
|